Peptide inhibition of acute lung injury in a novel two-hit rat model
暂无分享,去创建一个
M. Glesby | F. Lattanzio | A. Sampson | T. Vazifedan | N. Krishna | P. Hair | K. Cunnion | M. Gregory Rivera | K. Jackson | A. Enos | A. Werner | B. Lassiter
[1] O. Arrieta,et al. Radiation-induced lung injury: current evidence , 2021, BMC Pulmonary Medicine.
[2] Choongho Lee,et al. Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective , 2021, Archives of pharmacal research.
[3] Sumit Ghosh,et al. From virus to inflammation, how influenza promotes lung damage , 2020, Journal of leukocyte biology.
[4] L. Gershwin,et al. A Review of Neutrophil Extracellular Traps (NETs) in Disease: Potential Anti-NETs Therapeutics , 2020, Clinical Reviews in Allergy & Immunology.
[5] N. Schmidt,et al. Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19 , 2020, Frontiers in Immunology.
[6] John D Lambris,et al. Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis , 2020, medRxiv.
[7] N. Krishna,et al. Inhibition of complement activation, myeloperoxidase, NET formation and oxidant activity by PIC1 peptide variants , 2019, PloS one.
[8] C. E. van der Schoot,et al. The Role of Complement in Transfusion-Related Acute Lung Injury , 2019, Transfusion Medicine Reviews.
[9] J. Semple,et al. The Pathogenic Involvement of Neutrophils in Acute Respiratory Distress Syndrome and Transfusion-Related Acute Lung Injury , 2018, Transfusion Medicine and Hemotherapy.
[10] N. Krishna,et al. Inhibition of Immune Complex Complement Activation and Neutrophil Extracellular Trap Formation by Peptide Inhibitor of Complement C1 , 2018, Front. Immunol..
[11] N. Krishna,et al. Peptide Inhibitor of Complement C1 (PIC1) demonstrates antioxidant activity via single electron transport (SET) and hydrogen atom transfer (HAT) , 2018, PloS one.
[12] Nazita Yousefieh,et al. Peptide Inhibitor of Complement C1 (PIC1) Inhibits Growth of Pathogenic Bacteria , 2019, International Journal of Peptide Research and Therapeutics.
[13] N. Krishna,et al. Inhibition of Myeloperoxidase Activity in Cystic Fibrosis Sputum by Peptide Inhibitor of Complement C1 (PIC1) , 2017, PloS one.
[14] V. Janout,et al. Past and Present ARDS Mortality Rates: A Systematic Review , 2017, Respiratory Care.
[15] F. Lattanzio,et al. Peptide inhibitor of complement C1 modulates acute intravascular hemolysis of mismatched red blood cells in rats , 2016, Transfusion.
[16] N. Thielens,et al. Peptide Inhibitor of Complement C1 (PIC1) Rapidly Inhibits Complement Activation after Intravascular Injection in Rats , 2015, PloS one.
[17] F. Lattanzio,et al. Complement inhibition significantly decreases red blood cell lysis in a rat model of acute intravascular hemolysis , 2014, Transfusion.
[18] D. Wilkes,et al. Complement system in lung disease. , 2014, American journal of respiratory cell and molecular biology.
[19] M. Nicolls,et al. Complement components as potential therapeutic targets for asthma treatment. , 2014, Respiratory medicine.
[20] J. Ribeiro,et al. Epidemiological and genetic characteristics associated with the severity of acute viral bronchiolitis by respiratory syncytial virus. , 2013, Jornal de pediatria.
[21] Z. Werb,et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. , 2012, The Journal of clinical investigation.
[22] J. Hartwig,et al. Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice. , 2011, Blood.
[23] C. Silliman,et al. Transfusion-related acute lung injury. , 2006, Blood reviews.
[24] A. Paterson,et al. The association of biologically active lipids with the development of transfusion‐related acute lung injury: a retrospective study , 1997, Transfusion.